1546 results for Leukemia

Refine Your Search

FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia

FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia

The Leukemia & Lymphoma Society (LLS) helped every step of the way in discovery and development of menin inhibitors Rye Brook, N.Y., December , – The…

MOD PIZZA PARTNERS WITH THE LEUKEMIA & LYMPHOMA SOCIETY TO HELP KIDS WITH BLOOD CANCER

MOD PIZZA PARTNERS WITH THE LEUKEMIA & LYMPHOMA SOCIETY TO HELP KIDS WITH BLOOD CANCER

Funds Raised to Benefit the Work of LLS’s The Dare to Dream Project to Bring Safer, Less Toxic Treatments for Kids with Blood Cancer & Provide Free Su…

UFCW AND THE LEUKEMIA & LYMPHOMA SOCIETY ARE  UNITED IN THE FIGHT TO END CANCER

UFCW AND THE LEUKEMIA & LYMPHOMA SOCIETY ARE UNITED IN THE FIGHT TO END CANCER

Washington D.C. (September , ) - The United Food and Commercial Workers International Union (UFCW) and The Leukemia & Lymphoma Society (LLS) today ann…

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia

For Immediate ReleaseContact: Andrea GreifSenior Director of Communications()- (p))- (c)[email protected](White Plains, NY) - January , - Today's…

News Release

Subaru Partners with The Leukemia & Lymphoma Society for 8th Year to Share Warmth, Love and Relief with Patients Facing Cancer

Subaru of America, Inc. is renewing its partnership with The Leukemia & Lymphoma Society (LLS) during Subaru Loves to Care® month in June. Subaru will…

Leading Treatment for Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma Now Available in Tablet Form

Leading Treatment for Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma Now Available in Tablet Form

WASHINGTON, (June , ) – The U.S. Food and Drug Administration has approved a new tablet formulation of zanubrutinib (Brukinsa®) which is used to treat…

News Release

Breaking Data Presented at ASCO 2024 Showcase Breadth of The Leukemia & Lymphoma Society Therapy Acceleration Program Impact on Key Blood Cancer Research

Breaking Data Presented at ASCO 2024 Showcase Breadth of The Leukemia & Lymphoma Society Therapy Acceleration Program Impact on Key Blood Cancer Research

RYE BROOK, N.Y., May , – Four companies supported by The Leukemia & Lymphoma Society Therapy Acceleration Program (LLS TAP) are presenting new data f…

Wawa and The Leukemia & Lymphoma Society Celebrate a Decade of Impact During National Volunteer Week

Wawa and The Leukemia & Lymphoma Society Celebrate a Decade of Impact During National Volunteer Week

A Thoughtful Gift from Wawa Brings Relief to Families Facing Blood Cancer Fueling Hope, One Family at a Time WASHINGTON, APRIL , — As Wawa celebrates…

News Release

The Leukemia & Lymphoma Society (LLS) Named Charitable Partner of Largest Esports League in North America

The Leukemia & Lymphoma Society (LLS) Named Charitable Partner of Largest Esports League in North America

CSL Esports Creates Partnership to Develop Charitable Opportunities Through NACE Starleague

Get Involved

Research Funded by The Leukemia & Lymphoma Society Among Highlights at Annual American Society of Hematology

Research Funded by The Leukemia & Lymphoma Society Among Highlights at Annual American Society of Hematology

For Immediate ReleaseContact: Andrea Greif() [email protected] Plains, NY (December , ) - Many researchers funded by The Leukemia & Lymph…

The Leukemia & Lymphoma Society Launches New Initiative to Halt the Progression of Myeloid Blood Cancers

White Plains, NY (October , ) - The Leukemia & Lymphoma Society has initiated a program to fund research projects seeking to better understand and, ul…

The Leukemia & Lymphoma Society's Birmingham Light The Night Walk to be Chaired by Regions Executives

The Leukemia & Lymphoma Society's Birmingham Light The Night Walk to be Chaired by Regions Executives FRIDAY, FEBRUARY , ? The Alabama …

A Message From Dr. Louis J. DeGennaro, President and CEO of The Leukemia & Lymphoma Society

A Message From Dr. Louis J. DeGennaro, President and CEO of The Leukemia & Lymphoma Society

One of the things that I value most about leading The Leukemia & Lymphoma Society (LLS) is seeing our talented, dedicated and relentless staff and vol…

The Leukemia & Lymphoma Society Announces Board of Directors Officer Appointments and Welcomes Four New Members

The Leukemia & Lymphoma Society Announces Board of Directors Officer Appointments and Welcomes Four New Members

RYE BROOK, NY, July , - The Leukemia & Lymphoma Society (LLS) announced today National Board Officer appointments and four new members to its Nationa…

News Release

United by Courage: Siblings Named The Leukemia & Lymphoma Society’s National Student Visionaries of the Year

United by Courage: Siblings Named The Leukemia & Lymphoma Society’s National Student Visionaries of the Year

More than , high school leaders across the U.S. led the way to raise over $ million setting new fundraising record to help blood cancer patients See f…

News Release

FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of Acute Leukemia

FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of Acute Leukemia

The Leukemia & Lymphoma Society (LLS) was an early champion and funder of CAR therapy Rye Brook, N.Y., December , – The U.S. Food and Drug Administr…

The Leukemia & Lymphoma Society Named in Fast Company’s Second Annual List of “Brands That Matter”

The Leukemia & Lymphoma Society Named in Fast Company’s Second Annual List of “Brands That Matter”

[Rye Brook, NY], October , – Fast Company announced today its second annual Brands That Matter list, honoring brands that communicate and demonstrate…

Dare 2 Dream

Louis J. DeGennaro, Ph.D., to Retire as President and CEO of The Leukemia & Lymphoma Society

Rye Brook, N.Y., May , – The Leukemia & Lymphoma Society (LLS) announced today the intent of Louis J. DeGennaro, Ph.D., president and CEO, to retire …

Louis J. DeGennaro, Ph.D., Named President and Chief Executive Officer of The Leukemia & Lymphoma Society

Louis J. DeGennaro, Ph.D., Named President and Chief Executive Officer of The Leukemia & Lymphoma Society

Contact: Andrea Greif() [email protected] Plains, NY (September , ) - The Leukemia & Lymphoma Society (LLS) announced today that Louis J.…

The Leukemia & Lymphoma Society Financial Relief Fund Commits Over $1 Million in Direct Support to Blood Cancer Patients Impacted by Hurricanes Fiona & Ian

Rye Brook, NY – October , – In the wake of the destruction caused by Hurricane Fiona and Hurricane Ian, The Leukemia & Lymphoma Society (LLS) announc…

News Release

Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine is Safe but 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies

Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine is Safe but 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies

About : blood cancer patients fail to produce detectable antibodies after vaccination with results varying substantially by type of blood cancer, acc…

The Leukemia & Lymphoma Society (LLS) Data and Presence at ASH Showcase Latest Blood Cancer Treatment Breakthroughs

The Leukemia & Lymphoma Society (LLS) Data and Presence at ASH Showcase Latest Blood Cancer Treatment Breakthroughs

Numerous researchers and Therapy Acceleration Program (TAP) partners will present data on the most recent developments in blood cancer.LLS’s scientif…

News Release

Targeting Oncoembryonic Antigens ROR1 and ROR2 For Therapy Of Patients With Hairy Cell Leukemia

We will study the function of ROR1 and ROR2 on HCL cells that we have collected from patients, examining whether they influence expression of genes t…